News for XTL Biopharmaceuticals Ltd. (XTLB)

News for XTL Biopharmaceuticals Ltd.
Date Headline
Nov 09, 2016 01:25 PM XTL Biopharmaceuticals Receives NASDAQ Notification Regarding Minimum Bid Requirements
Sep 27, 2016 08:30 AM XTL Biopharmaceuticals Reports Second Quarter 2016 Financial Results & Provides Clinical and Operational Update
Sep 07, 2016 08:32 AM XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug hCDR1
Sep 06, 2016 08:00 AM XTL Biopharmaceuticals to Present at Rodman & Renshaw Conference on September 12, 2016
Aug 11, 2016 09:00 AM XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1
Jun 01, 2016 08:30 AM XTL Biopharmaceuticals Reports First Quarter 2016 Financial Results & Provides Clinical and Operational Update
May 16, 2016 11:45 AM XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016
Apr 07, 2016 01:04 PM XTL BIOPHARMACEUTICALS LTD Financials
Mar 31, 2016 09:45 AM XTL Biopharmaceuticals Reports 2015 Financial Results & Provides Clinical and Operational Update
Mar 21, 2016 08:30 AM XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus